Skip to main content
SpringerLink
Log in
Book cover

Principles and Practice of Environmental Medicine pp 217–240Cite as

Disorders of the Nervous System

  • Chapter

Abstract

The nervous system, in spite of its seemingly protected environment, is vulnerable to the effects of a host of toxins. Although the precise reasons for this vulnerability remain uncertain, the heterogeneity of cell types, the coatings required by many of the axons, and the rich blood supply needed by the metabolically active cells all present opportunities for many toxins to exert a noxious effect. Once attacked, the nervous system repairs itself poorly if at all, and the resulting dysfunction often endures. At times minor neural damage can create noticeable, even disabling, symptoms. Numerous authors have reviewed the effects of neurotoxic exposure (14, 15, 42, 46, 86, 103, 115).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ad Hoc Working Group, International Agency for Research on Cancer: Extremely low frequency electric and magnetic fields and risk of human cancer. Bioelectromagnetics 11:91, 1990.

    Article  Google Scholar 

  2. Ahlbom A: A review of the epidemiologic literature on magnetic fields and cancer. Scand J Work Environ Health 14:337, 1988.

    Article  PubMed  CAS  Google Scholar 

  3. Alexander FW: The uptake of lead by children in differing environments. Environ Health Perspect 7:155, 1974.

    Article  PubMed  CAS  Google Scholar 

  4. Alfrey AC, LeGendre GR, Kaethny WE: The dialysis encephalopathy syndrome: Possible aluminum intoxication. N Engl J Med 294:184, 1976.

    Article  PubMed  CAS  Google Scholar 

  5. Allen N: Solvents and other industrial organic compounds. In: Handbook of Clinical Neurology, Vol. 36, p 361, Vinken PJ, Bruyn GW (eds.), North-Holland, Amsterdam, 1979.

    Google Scholar 

  6. Allen N: Identification of methyl n-butyl ketone as the causative agent. In: Experimental and Clinical Neurotoxicology, p 834, Spencer PS, Schaumburg HH (eds.), Williams & Wilkins, Baltimore, 1980.

    Google Scholar 

  7. Allen N, Mendell JR, Billmair JD, et al: Toxic neuropathy due to methyl n-butyl ketone. Arch Neurol 32:209, 1975.

    Article  PubMed  CAS  Google Scholar 

  8. Almog C, Tal E: Death from paraquat after subcutaneous injection. Br Med J 3:721, 1967.

    Article  PubMed  CAS  Google Scholar 

  9. American Medical Association: Health Effects of “Agent Orange” and Polychlorinated Dioxin Contaminants, AMA, Chicago, 1981.

    Google Scholar 

  10. American Medical Association: Health Effects of “Agent Orange” and Polychlorinated Dioxin Contaminants: An update, AMA, Chicago, 1984.

    Google Scholar 

  11. Andrews LS, Snyder R: Toxic effects of solvents and vapors. In: Casarett and Doull’s Toxicology The Basic Science of Poisons, 3rd ed., p 636, Klaassen CD, Amdur MO, Doull J (eds.), Macmillan, New York, 1986.

    Google Scholar 

  12. Anger WK, Johnson BL: Chemicals affecting behavior. In: Neurotoxicity of Industrial and Commercial Chemicals, Vol. 1, O’Donoghue JL (ed.), CRC Press, Boca Raton, 1985.

    Google Scholar 

  13. Arezzo JC, Schaumburg NH, Peterson CA: Rapid screening for peripheral neuropathy: A field study with the Optacon. Neurology 33:626, 1983.

    Article  PubMed  CAS  Google Scholar 

  14. Baker EL: Neurological and behavioral disorders. In: Occupational Health: Recognizing and Preventing Work-Related Disease, 2nd ed., p 399, Levy BS, Wegman DH (eds.), Little Brown, Boston, 1989.

    Google Scholar 

  15. Baker EL, Feldman RG, French JG: Environmentally related disorders of the nervous system. Med Clin North Am 74:325, 1990.

    PubMed  CAS  Google Scholar 

  16. Bakir F, Damluji SF, Amin-Zaki L, et al: Methyl-mercury in Iraq. Science 181:230, 1973.

    Article  PubMed  CAS  Google Scholar 

  17. Barbeau A: Etiology of Parkinson’s disease: A research strategy. Can J Neurosci 11:1457, 1983.

    Google Scholar 

  18. Barnes GE: Solvent abuse: A review. Int J Addict 14:1, 1979.

    PubMed  CAS  Google Scholar 

  19. Baselt RC, Cravey RH: Disposition of Toxic Drugs and Chemicals in Man, 3rd ed., Year Book Medical Publishers, Chicago, 1990.

    Google Scholar 

  20. Batigelli MC: Mercury. In: Environmental and Occupational Medicine, p 449, Rom WN (ed.), Little, Brown, Boston, 1983.

    Google Scholar 

  21. Bennett DG Jr, Schwartz TE: Cumulative toxicity of lead arsenate in phenothiazine given to sheep. Am J Vet Res 32:727, 1971.

    PubMed  CAS  Google Scholar 

  22. Berwick P: 2,4-Dichlorophenoxyacetic acid poisoning in man: Some interesting clinical and laboratory findings. JAMA 214:1114, 1970.

    Article  PubMed  CAS  Google Scholar 

  23. Birke G, Johenls AG, Plantin LO, et al: Studies on humans exposed to methylmercury through fish consumption. Arch Environ Health 25:77, 1972.

    Article  PubMed  CAS  Google Scholar 

  24. Bocchetta A, Bernardi F, Piccardi MP, et al: MPTP model: Renewed interest in environmental factors in Parkinson’s disease. In: Neurodegenerative Disorders: The Role Played by Endotoxins and Xenobiotics, p 121, Nappi G, Hornykiewicz O, Fariello RG, et al. (eds.), Raven Press, New York, 1988.

    Google Scholar 

  25. Buckley J, Warlow C, Smith P, et al: Motor neuron disease in England and Wales, 1959–1979. J Neurol Neurosurg Psychiatry 46:197, 1983.

    Article  PubMed  CAS  Google Scholar 

  26. Calne DB, McGeer E, Eisen A, et al: Alzheimer’s disease, Parkinson’s disease and motoneuron disease: Abiotropic interaction between ageing and environment. Lancet 2:1067, 1986.

    Article  PubMed  CAS  Google Scholar 

  27. Caine S, Schoenberg B, Martin W, et al: Familial Parkinson’s disease: Possible role of environmental factors. Can J Neurol Sci 14:303, 1987.

    Google Scholar 

  28. Cannon SB, Veazey JM Jr, Jackson RS, et al: Epidemic kepone poisoning in chemical workers. Am J Epidemiol 107:529, 1978.

    PubMed  CAS  Google Scholar 

  29. Cavanaugh JB, Holler WC: Tri-ortho-cresyl phosphate poisoning. In: The Handbook of Clinical Neurology, Vol. 37, p 471, Vinken PJ, Bruyn GW (eds.), North-Holland, Amsterdam, 1979.

    Google Scholar 

  30. Centers for Disease Control: Preventing Lead Poisoning in Young Children, A Statement by the Centers for Disease Control, CDC, Atlanta, 1991.

    Google Scholar 

  31. Chiappa KH, Ropper AH: Evoked potentials in clinical medicine, I and II. N Engl J Med 306:1140–1150, 1205–1211, 1982.

    Article  PubMed  CAS  Google Scholar 

  32. Cohn NJ, Boylan JJ, Blanke RV: Treatment of chlordecone (Kepone) toxicity with cholestyramine. N Engl J Med 298:243, 1978.

    Article  PubMed  CAS  Google Scholar 

  33. Coleman M, Beral V: A review of epidemiological studies of the health effects of living near or working with electricity generation and transmission equipment. Int J Epidemiol 17:1, 1988.

    Article  PubMed  CAS  Google Scholar 

  34. Cordle R, Locke R, Springer J: Risk assessment in a federal regulatory agency: An assessment of risk associated with the human consumption of some species of fish contaminated with polychlorinated biphenyls (PCBs). Environ Health Perspect 45:171, 1982.

    Article  PubMed  CAS  Google Scholar 

  35. Coulston F, Pocchiari F (eds.): Accidental Exposure to Dioxins. Academic Press, Orlando, 1983.

    Google Scholar 

  36. Craft BF: Solvents and related compounds. In: Environmental and Occupational Medicine, p 511, Rom WN (ed.), Little, Brown, Boston, 1983.

    Google Scholar 

  37. Davis DL, Hoel D, Fox J, et al: International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet 2:474, 1990.

    Article  Google Scholar 

  38. Environmental Studies Board, Commission on Natural Resources: Urban Pest Management, National Academy Press, Washington, 1980.

    Google Scholar 

  39. Falk RJO, Snihs L, Ekman U, et al: Whole body measurements of the distribution of mercury 203 in humans after oral intake of methylradiomercury nitrate. Acta Radiol 9:55, 1971.

    Google Scholar 

  40. Fawer RF, de Ribaupierre Y, Guillemen MP, et al: Hand tremor measurements: Methodology and application. In: Advances in the Biosciences, Vol 46, Neurobehavioral Methods in Occupational Health, p 137, Gilioli R (ed.), Pergamon Press, New York, 1983.

    Google Scholar 

  41. Feinglass M: Arsenic intoxication from well water in the United States. N Engl J Med 288:828, 1973.

    Article  PubMed  CAS  Google Scholar 

  42. Feldman R: Effects of toxins and physical agents on the nervous system. In: Neurology in Clinical Practice, p 1185, Bradley DM, Daroff R, Fenichil G, et al. (eds.), Butterworths, London, 1990.

    Google Scholar 

  43. Fischbein A: Environmental and occupational lead exposure. In: Environmental and Occupational Medicine, p 433, Rom WN (ed.), Little, Brown, Boston, 1983.

    Google Scholar 

  44. Flaten TP: Rising mortality from motoneuron disease. Lancet 1:1018, 1989.

    Article  PubMed  CAS  Google Scholar 

  45. Friberg L, Vostal J: Mercury in the Environment: An Epidemiologic and Toxicologic Appraisal. CRC Press, Boca Raton, 1972.

    Google Scholar 

  46. Gailli CL, Manzo L, Spencer PS (eds.): Recent Advances in Nervous System Toxicology, Plenum Press, New York, 1984.

    Google Scholar 

  47. Gluck L, Wood HR: Staphylococcal colonization in newborn infants with and without antiseptic skin care. N Engl J Med 268:1265, 1963.

    Article  PubMed  CAS  Google Scholar 

  48. Goldsmith JR, Herishanu Y, Agarbanel JM, et al: Clustering of Parkinson’s disease points to environmental etiology. Arch Environ Health 45:89, 1990.

    Article  Google Scholar 

  49. Gosselin RE, Smith RP, Hodge HC: Clinical Toxicology of Commercial Products, Williams & Wilkins, Baltimore, 1984.

    Google Scholar 

  50. Goyer RA: Toxic effects of metals. In: Casarett and Doull’s Toxicology: The Basic Science of Poisons, 3rd ed., p 582, Klaassen CD, Amdur MO, Doull J (eds.), Macmillan, New York, 1986.

    Google Scholar 

  51. Graf JW: Clinical aspects of lead poisoning. In: Handbook of Clinical Neurology, Vol. 36, p 1, Vinken PJ, Bruyn CW (eds.), North-Holland, Amsterdam, 1979.

    Google Scholar 

  52. Guzelian PS: Comparative toxicology of chlordecone (Kepone) in humans and experimental animals. Annu Rev Pharmacol Toxicol 22:89, 1982.

    Article  PubMed  CAS  Google Scholar 

  53. Hayes WJ Jr: Pesticides Studied in Man. Williams & Wilkins, Baltimore, 1982.

    Google Scholar 

  54. Hertzman C, Wiens M, Bowering J, et al: Parkinson’s disease: A case-control of occupational and environmental risk factors. Am J Ind Med. 17:349, 1990.

    Article  PubMed  CAS  Google Scholar 

  55. Heyman A, Pfeiffer JB Jr, Willett RW, et al: Peripheral neuropathy caused by arsenical intoxication: A study of 41 cases with observations on the effect of BAL (2,3-dimercapto-propanol). N Engl J Med 254:401, 1956.

    Article  PubMed  CAS  Google Scholar 

  56. Hindmarsh JT, McLetchie OR, Hefferman LPM, et al: Electromyographic abnormalities in chronic environmental arsenicism. J Anal Toxicol 1:270, 1977.

    Article  CAS  Google Scholar 

  57. Ho SC, Woo J, Lee CM: Epidemiologic study of Parkinson’s disease in Hong Kong. Neurology 39:1314, 1989.

    Article  PubMed  CAS  Google Scholar 

  58. Huff JE, Moore JA, Aracci R, et al: Long term hazards of polychlorinated dibenzodioxins and polychlorinated dibenzofurarts. Environ Health Perspect 36:221, 1980.

    Article  PubMed  CAS  Google Scholar 

  59. Jacobs MB, Ladd AC, Goldwater LJ: Absorption and excretion of mercury in Man. VI: Significance of mercury in urine. Arch Environ Health 9:454, 1964.

    Article  PubMed  CAS  Google Scholar 

  60. Jenkins RB: Inorganic arsenic and the nervous system. Brain 89:479, 1966.

    Article  PubMed  CAS  Google Scholar 

  61. Kimbrough RD, Jensen AA (eds.): Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins and Related Products, 2nd ed., Elsevier, Amsterdam, 1989.

    Google Scholar 

  62. King MD, Day RE, Oliver JS, et al: Solvent encephalopathy. Br Med J 283:664, 1981.

    Google Scholar 

  63. Kohli JD, Khanna RN, Gutta BN, et al: Absorption and excretion of 2,4-dichlorophenoxyacetic acid in man. Xenobiotica 4:97, 1974.

    Article  PubMed  CAS  Google Scholar 

  64. Koller WC, Klawans HL: Organophosphorus intoxication. In: Handbook of Clinical Neurology, Vol 37, p 541, Vinken PJ, Bruyn GS (eds.), North-Holland, Amsterdam, 1979.

    Google Scholar 

  65. Kopin IJ, Markey SP: MDTP toxicity implications for research in Parkinson’s disease. Annu Rev Neurosci 11:81, 1988.

    Article  PubMed  CAS  Google Scholar 

  66. Kuratsune M: Yusho, with reference to Yu-Cheng. In: Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins and Related Products, Kimbrough RD, Jensen AA (eds.), 2nd ed., p. 381, Elsevier, Amsterdam, 1989.

    Chapter  Google Scholar 

  67. Kurolwa Y, Mural Y, Santa T: Neurological and nerve conduction velocity. Fukuoka Acta Med 60:462, 1969.

    Google Scholar 

  68. Landrigan PJ: Arsenic state of the art. Am J Ind Med 2:5, 1981.

    Article  PubMed  CAS  Google Scholar 

  69. Landrigan PJ, Baker EL, Feldman RG, et al: Increased lead absorption with anemia and slowed nerve conduction in children near a lead smelter. J Pediatr 89:904, 1976.

    Article  PubMed  CAS  Google Scholar 

  70. Langston JW, Ballard PA: Parkinson’s disease in a chemist working with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Lancet 1:747, 1985.

    PubMed  Google Scholar 

  71. Langston JW, Ballard P, Tetrud JW, et al: Chronic parkinsonism in humans due to a product of merperidine-analogue synthesis Science 219:979, 1982.

    Article  Google Scholar 

  72. Lewis JD, Moritz D, Mellis LP: Long term toluene abuse. Am J Psychiatry 138:368, 1981.

    PubMed  CAS  Google Scholar 

  73. Lilienfeld DE, Chan E, Ehland J, et al: Rising mortality from motoneuron disease in the USA, 1962–84. Lancet 1:710, 1989.

    Article  PubMed  CAS  Google Scholar 

  74. Lush M, Oliver JS, Watson JM: The analysis of blood in cases of suspected solvent abuse with a review of results during the period October 1977 to July 1979. In: Forensic Toxicology: Proceedings of the European Meeting of the International Association of Forensic Toxicologists, p 301, Oliver JS (ed.), Croom Helm, London, 1980.

    Google Scholar 

  75. Marsh D: Organic mercury: methylmercury compounds. In: Handbook of Clinical Neurology, Vol 36, p 73, Vinken JP, Bruyn GS (eds.), North-Holland, Amsterdam, 1979.

    Google Scholar 

  76. Marshall E: The rise and decline of Temik. Science 229:1369, 1985.

    Article  PubMed  CAS  Google Scholar 

  77. Masuda Y, Yashimur H: Polychlorinated biphenyls and dibenzofurans in patients with Yusho and their toxicological significance. Am J Ind Med 5:31, 1984.

    PubMed  CAS  Google Scholar 

  78. Mathews HB, Dedrick RL: Pharmokinetics of polychlorinated biphenyls. Annu Rev Pharmacol Toxicol 24:85, 1984.

    Article  Google Scholar 

  79. Mealey J Jr, Brownwell GL, Sweet WH: Radiarsenile in plasma, urine, normal tissues and intracranial neoplasms. AMA Arch Neurol Psychiatry 81:310, 1959.

    Article  PubMed  CAS  Google Scholar 

  80. Morgan DP: Recognition and Management of Pesticide Poisoning, 4th ed, US Environmental Protection Agency, EPA 540/9–88–001, Washington, 1989.

    Google Scholar 

  81. Mulder DW, Kuland LT, Marte LLG: Neurologic diseases on the island of Guam, US. Armed Forces Med J 5:1724, 1954.

    CAS  Google Scholar 

  82. Murphy SD: Toxic effects of pesticides. In: Casarett and Doull’s Toxicology: The Basic Science of Poisons, 3rd ed, p 519, Klaassen CD, Amdur MO, Doull J (eds.), Macmillan, New York, 1986.

    Google Scholar 

  83. Mushak P: Biological monitoring of lead exposure in children: Overview of selected biokinetic and toxicologial issues. In: Lead Exposure and Child Development an International Assessment, p 129, Smith MA, Grant LD, Sors AI (eds.), Kluwer Academic, Dordrecht, 1988.

    Google Scholar 

  84. Mushak P, Davis MJ, Crocetti AF, et al: Prenatal and postnatal effects of low-level lead exposure: Integrated summary of a report to the U.S. Congress on childhood lead poisoning. Environ Res 50:11, 1989.

    Article  PubMed  CAS  Google Scholar 

  85. Neilson VK: The peripheral nerve function in chronic renal failure: An analysis of the vibratory perception threshold. Acta Med Scand 191:287, 1972.

    Google Scholar 

  86. Norton S: Responses of the central nervous system. In: Casarett and Doull’s Toxicology: The Basic Science of Poisons, 3rd ed, p 359, Klaassen CD, Amdur MO, Doull J (eds.), Macmillan, New York, 1986.

    Google Scholar 

  87. Oyangurem H, Perez E: Poisoning of industrial origin in the community. Arch Environ Health 13:185, 1966.

    Article  Google Scholar 

  88. Pazderova-Vejlupkova J, Lukas E, Numcova M, et al: The development and prognosis of chronic intoxication by tetrachlordibenzo-p-dioxin in men. Arch Environ Health 36:5, 1981.

    Article  PubMed  CAS  Google Scholar 

  89. Perlstein MA, Attala R: Neurologic sequelae of plumbism in children. Clin Pediatr 5:292, 1966.

    Article  Google Scholar 

  90. Rabinowitz MB, Wetherill GW, Kopple JD: Studies of human lead metabolism by use of stable isotope tracers. Environ Health Perspect 7:145, 1974.

    Article  PubMed  CAS  Google Scholar 

  91. Rabinowitz MB, Wetherill GW, Kopple JD: Kinetic analysis of lead metabolism in healthy humans. J Clin Invest 58:260, 1976.

    Article  PubMed  CAS  Google Scholar 

  92. Reed DM, Brody JA: Amyotrophic lateral sclerosis and parkinsonism dementia on Guam, 1945–1972. Am J Epidemiol 101:287, 1975.

    PubMed  CAS  Google Scholar 

  93. Reggiani G: Estimation of the TCDD toxic potential in the light of the Seveso accident. Arch Toxicol Suppl 2:291, 1979.

    Article  PubMed  Google Scholar 

  94. Reggiani GM: The Seveso accident: Medical survey of a TCDD exposure. In: Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins and Related Products, 2nd ed., p 45, Kimbrough RD, Jensen AA (eds.), Elsevier, Amsterdam, 1989.

    Google Scholar 

  95. Rogan WJ: Yu-Cheng. In: Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins and Related Products, 2nd ed., p 401, Kimbrough RD, Jensen AA (eds.), Elsevier, Amsterdam, 1989.

    Chapter  Google Scholar 

  96. Rustam H, Hamdi T: Methyl mercury poisoning in Iraq. Brain 97:499, 1974.

    Article  Google Scholar 

  97. Savitz DA, Wachtel H, Barnes FA, et al: Case control study of childhood cancer and exposure to 60-Hz magnetic fields. Am J Epidemiol 128:21, 1988.

    PubMed  CAS  Google Scholar 

  98. Savitz DA, John EM, Kleckner RC: Magnetic field exposure from electric appliances and childhood cancer. Am J Epidemiol 131:763, 1990.

    PubMed  CAS  Google Scholar 

  99. Schuman RM, Leech RW, Alvord ED Jr: Neurotoxicity of hexachlorophene in the human. A clinico-pathologic study of 248 children. Pediatrics 54:689, 1973.

    Google Scholar 

  100. Schuman RM, Leech RW, Alvord ED Jr: Neurotoxicity of hexachlorophene in the human. Arch Neurol 32:320, 1975.

    Article  Google Scholar 

  101. Seppalainen AM, Hernberg S: Sensitive techniques for detecting subclinical lead neuropathy. Br J Ind Med 29:443, 1972.

    PubMed  CAS  Google Scholar 

  102. Seto DYS, Freeman JM: Lead neuropathy in childhood. Am J Dis Child 107:337, 1964.

    PubMed  CAS  Google Scholar 

  103. Spencer PS, Schaumburg HH (eds.): Experimental and Clinical Neurotoxicology, Williams & Wilkins, Baltimore, 1980.

    Google Scholar 

  104. Spencer PS, Schaumburg HH: An expanded classification of neurotoxic responses based on cellular targets of chemical agents. Acta Neurol Scand 70(Suppl 100):9, 1984.

    Google Scholar 

  105. Spencer PS, Nunn PB, Hugon J, et al: Motor neuron disease on Guam: Possible role of a food neurotoxin. Lancet 2:965, 1986.

    Article  Google Scholar 

  106. Spencer PS, Roy DN, Ludolph A, et al: Lathyrism: Evidence for role of the neuroexcitatory BOAA. Lancet 2:1066, 1986.

    Article  PubMed  CAS  Google Scholar 

  107. Spencer PS, Nunn PB, Hugon J, et al: Guam amyotrophic lateral sclerosis-Parkinson-dementia linked to a plant excitant neurotoxin. Science 237:517, 1987.

    Article  PubMed  CAS  Google Scholar 

  108. Suskind RR, Hertzberg VS: Human health effects of 2,4,5-T and its toxic contaminants. JAMA 257:2372, 1984.

    Article  Google Scholar 

  109. Takeuchi T, Eto N, Eto K: Neuropathology of childhood cases of methylmercury poisoning (Minamata disease) with prolonged symptoms with particular reference to the decortication syndrome. Neurotoxicology 1:1, 1979.

    Google Scholar 

  110. Tanner CM: The role of environmental toxins in the etiology of Parkinson’s disease. Trends Neurosci 12:49, 1989.

    Article  PubMed  CAS  Google Scholar 

  111. Tanner CM, Chen B, Wang W, et al: “Environmental factors” and Parkinson’s disease: A case-control study in China. Neurology 39:660, 1989.

    Article  PubMed  CAS  Google Scholar 

  112. Taylor JR, Selhorst JB, Houff SA, et al: Chlordecone intoxication in man: I: Clinical observations. Neurology 28:626, 1978.

    Article  PubMed  CAS  Google Scholar 

  113. Taylor JR, Selhorst JB, Calabrese VP: Chlordecone. In: Experimental and Clinical Neurotoxicology, p 407, Spencer PS, Schaumburg HH (eds.), Williams & Wilkins, Baltimore, 1980.

    Google Scholar 

  114. US Congress, Office of Technology Assessment: Losing a Million Minds: Confronting the Tragedy of Alzheimer’s Disease and Other Dementias, US Government Printing Office, Washington, 1987.

    Google Scholar 

  115. US Congress, Office of Technology Assessment: Neurotoxicity: Identifying and Controlling Poisons of the Nervous System, Van Nostrand Reinhold, New York, 1990.

    Google Scholar 

  116. US Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry: The Nature and Extent of Lead Poisoning in Children in the United States: A Report to Congress, Centers for Disease Control, Atlanta, 1988.

    Google Scholar 

  117. US Environmental Protection Agency: Suspended, Cancelled and Restricted Pesticides, 3rd revision, Washington, 1985.

    Google Scholar 

  118. US Environmental Protection Agency, Office of Pesticides and Toxic Substances: The Toxic Release Inventory: A National Perspective, 1987 EPA 560/4–89–006, Washington, 1989.

    Google Scholar 

  119. US Environmental Protection Agency, Office of Water, Office of Pesticides and Toxic Substances: National Pesticide Survey, Phase 1 Report: EPAs National Survey of Pesticides in Drinking Water Wells. EPA 570/9–90–015, Washington, 1990.

    Google Scholar 

  120. Winter CK, Seiber JN, Nuckton CF: Chemicals in the Human Food Chain, Van Nostrand Reinhold, New York, 1990.

    Google Scholar 

  121. World Health Organization: Principles and Methods for the Assessment of Neurotoxicity Associated with Exposure to Chemicals. Environmental Health Criteria 60, World Health Organization, Geneva, 1986.

    Google Scholar 

  122. Wright JM, Wall RA, Perry TL, et al: Chronic parkinsonism secondary to intranasal administration of a product of meperidine-analogue synthesis. N Engl J Med 310:325, 1984.

    PubMed  CAS  Google Scholar 

Recommended Readings

  • Baker EL, Feldman RG, French JG: Environmentally related disorders of the nervous system. Med Clin North Am 74:325, 1990.

    PubMed  CAS  Google Scholar 

  • Committee on Neurotoxicology and Models for Assessing Risk, National Research Council, National Academy Press, Washington, 1992.

    Google Scholar 

  • Feldman R: Effects of toxins and physical agents on the nervous system. In: Neurology in Clinical Practice, Vol II, p 1185, Bradley WG, Daroff RB, Fenichel GM, et al. (eds.), Butterworth Heinemann, London, 1991.

    Google Scholar 

  • Johnson BL (ed.): Preventing Neurotoxic Disease in Working Populations, John Wiley & Sons, New York, 1987.

    Google Scholar 

  • Spencer PS, Schaumburg HH (eds.): Experimental and Clinical Neurotoxicology, Williams & Wilkins, Baltimore, 1980.

    Google Scholar 

  • US Congress, Office of Technology Assessment: Neurotoxicity: Identifying and Controlling Poisons of the Nervous System, OTA-8A-436, US Government Printing Office, Washington, 1990.

    Google Scholar 

Download references

Authors
  1. John R. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Medicine, University of California, San Francisco, California, USA

    Alyce Bezman Tarcher M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Taylor, J.R. (1992). Disorders of the Nervous System. In: Tarcher, A.B. (eds) Principles and Practice of Environmental Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2447-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-2447-6_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-2449-0

  • Online ISBN: 978-1-4899-2447-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation